Company intelligence
Neuraxpharm
About Neuraxpharm
Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders, with a unique understanding of the CNS market. Neuraxpharm is constantly innovating, with new products and solutions to address unmet patient needs and is expanding its portfolio through its pipeline, partnerships, and acquisitions. The company has c.1,000 employees and develops and commercialises CNS products through a direct presence in more than 20 countries in Europe, two in Latin America, one in the Middle East, one in Australia, and globally via partners in more than 50 countries. Neuraxpharm is backed by funds advised by Permira. Neuraxpharm manufactures many of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain. To learn more about Neuraxpharm, please visit https://www.neuraxpharm.com
Verified activity
Signals from Neuraxpharm
4 published signals
Presence & Recognition
Neuraxpharm is participating in the 16th European Epilepsy Congress in Athens, where the European epilepsy community will exchange knowledge and new developments in epilepsy care.
Reported by Neuraxpharm
Presence & Recognition
Neuraxpharm employee Véronique Mujeriego will attend the 8th Drug-Device Combination Products Summit on 23-24 September 2026 in Amsterdam.
Reported by Véronique Mujeriego
Presence & Recognition
Neuraxpharm will be present at the 16th European Epilepsy Congress in Athens, Greece, from 5 to 9 September 2026, organised by ILAE Europe.
Reported by Neuraxpharm
People
Neuraxpharm hired Enric Alibech as Head of Security & Privacy (CISO) to lead the cybersecurity and privacy practice.
Reported by Enric Alibech